Status:
UNKNOWN
The Role of Pro-angiogenic Immune Cells in Human Pregnancies
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Fetal Growth Retardation
Preeclampsia
Eligibility:
FEMALE
Brief Summary
Identification of the presence of proangiogenic immune cells in normal human placentas may enable predication of some pregnancy disorders.
Eligibility Criteria
Inclusion
- Placentas that have been delivered in the Medical Center
Exclusion
- None
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01177020
Start Date
August 1 2010
End Date
December 1 2011
Last Update
August 6 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe Medical Center
Hadera, Israel, 38100